68

Qingdao Haier Biomedical Co Ltd

688139 · SHG · Healthcare / Medical Devices

31.21CNY-0.83 (-2.59%)

Price History

Full chart

Market Stats

Previous Close32.04
Open32.10
Day Range31.03 – 32.49
52-Week Range24.40 – 38.80
Volume3.61M
Market Cap11.35B
P/E (TTM)43.72
Forward P/E0.00
EPS0.82
Dividend Yield0.92%
Beta0.54
50-Day Avg30.37
200-Day Avg31.17

About

Qingdao Haier Biomedical Co.,Ltd engages in the research and development, manufacture, marketing, and sale of low temperature storage equipment for biomedical samples in China and internationally. The company offers ULT freezers, pharmacy refrigerators, freezers, automatic storage solutions, cryogenics, active temperature controlled RKN containers, and RTMD products; and CO2 incubation, standard incubators, biological safety cabinets, clean benches and laminar, and sterilization products. It also provides floor standing, benchtop refrigerated, and benchtop centrifuges; intelligent pharmacy automation and RFID pharmacy products; blood bank refrigerators, blood component management products, blood plasma freezers, and transport coolers; and vaccine storage, cold/freezer room, medical waste disposal equipment, and other products. In addition, the company offers freezer and controlled rate freezers; microwave digestion system; UV visible spectrophotometer and total organic carbon analyzer products; and consumables. Further, it provides after-sales services; and U-biobank, U-vaccine, U-reagent, U-blood, and U-laboratory network solutions. The company serves hospitals, bio and pharmaceutical enterprises, universities and colleges, scientific research institutions, centers for disease control, primary public health institutions and blood stations. Qingdao Haier Biomedical Co.,Ltd was founded in 2005 and is based in Qingdao, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. Zhanjie Liu
  • Employees2.89K
  • HeadquartersNo. 280 Feng Yuan Road, Qingdao, China, 266114, China
  • Websitehttps://www.haierbiomedical.com

Leadership

  • Dr. Zhanjie LiuGM & Employee Representative Director · b. 1970
  • Ms. Ruijuan MoChief Financial Officer · b. 1981
  • Ms. Yanli HuangBoard Secretary · b. 1987
  • Nai Juan MuAccounting Supervisor
  • Mr. Ji Yuan LiuExecutive Officer · b. 1984
  • Mr. Pei Kun TengPlanning Director and Head of the Tianjin R&D Center · b. 1986

Financials

Income Statement

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue481.98M621.41M841.67M1.01B1.40B2.13B2.86B2.28B2.28B2.33B
Growth (%)-+28.93%+35.45%+20.30%+38.47%+51.63%+34.72%-20.36%+0.13%+1.96%
Cost of Revenue227.02M292.85M414.53M469.51M694.11M1.06B1.48B1.17B1.19B1.24B
Gross Profit254.97M328.55M427.14M543.01M707.92M1.07B1.38B1.11B1.10B1.09B
Gross Margin52.90%52.87%50.75%53.63%50.49%50.15%48.15%48.60%47.99%46.79%
Operating Expense127.02M266.07M318.27M334.47M386.20M602.48M784.64M773.12M752.55M855.25M
Operating Income127.94M62.48M108.87M208.54M321.72M463.54M594.53M335.44M343.37M234.32M
Operating Margin26.55%10.06%12.93%20.60%22.95%21.80%20.76%14.71%15.03%10.06%
EBITDA-97.55M183.36M222.78M447.17M1.01B742.08M541.45M525.90M394.21M
EBITDA Margin-15.70%21.79%22.00%31.89%47.73%25.91%23.74%23.03%16.93%
Net Income123.21M60.39M113.96M182.06M380.95M845.04M600.79M406.07M366.63M250.73M
Net Income Margin25.56%9.72%13.54%17.98%27.17%39.75%20.98%17.80%16.05%10.77%
R&D35.67M82.88M90.35M121.36M150.72M236.31M292.47M320.64M306.17M323.25M
R&D as % of Total Revenue7.40%13.34%10.74%11.99%10.75%11.12%10.21%14.06%13.41%13.88%
Interest Expense0032.76M337.12K83.36K2.89M2.69M3.51M3.41M3.91M
Interest Expense % of Total Revenue0.00%0.00%3.89%0.03%0.01%0.14%0.09%0.15%0.15%0.17%

Balance Sheet

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets949.27M1.19B2.23B3.04B3.94B4.90B5.49B5.53B5.79B5.79B
Total Liabilities226.46M575.92M1.11B581.08M1.16B1.26B1.34B1.09B1.17B1.17B
Total Equity722.81M614.76M1.11B2.45B2.78B3.62B4.02B4.23B4.37B4.38B
Cash135.14M145.01M372.18M1.41B1.85B774.39M951.78M1.27B901.23M843.83M
Net Debt--187.05M-------

Cash Flow

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow220.72M148.32M149.00M280.49M696.62M632.43M632.43M249.26M291.67M267.89M
Investing Cash Flow-423.31M-114.08M-763.97M373.28M-135.22M-1.50B-251.17M---
Financing Cash Flow-826.23M826.23M374.54M-145.16M-136.01M----
Capital Expenditure14.50M26.98M69.33M168.40M88.99M204.69M294.24M177.18M126.70M119.25M
Free Cash Flow-121.35M79.67M112.09M607.63M387.11M338.18M72.08M164.96M148.64M
Dividends Paid-244.98M244.98M25.73M57.07M120.83M162.46M142.80M163.09M147.36M
FCF to OCF-81.81%53.47%39.96%87.23%61.21%53.47%28.92%56.56%55.48%
Dividend Paid to FCF-201.88%307.50%22.96%9.39%31.21%48.04%198.10%98.86%99.14%

Earnings

Report DateOct 30, 2019Mar 25, 2020Apr 28, 2020Aug 20, 2020Oct 27, 2020Feb 22, 2021Apr 27, 2021Aug 24, 2021Oct 26, 2021Feb 16, 2022Apr 28, 2022Aug 25, 2022Oct 23, 2022Feb 27, 2023Apr 25, 2023
EPS Estimate0.000.00-------------
EPS Actual0.180.200.220.270.370.311.320.480.400.460.360.590.510.440.43
Surprise---------------
TimingAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hours

Key Statistics & Ratios

Market Cap11.35B
Enterprise Value9.64B
Trailing P/E43.72
Forward P/E0.00
Price / Sales4.67
Price / Book2.51
EPS0.82
Book Value14.13
Revenue (TTM)2.43B
Gross Profit (TTM)1.14B
EBITDA316.68M
Profit Margin10.51%
Operating Margin10.03%
Return on Equity5.57%
Return on Assets2.33%
Shares Outstanding316.49M
Shares Float149.17M
Beta0.54
Dividend Yield0.92%
Dividend Rate0.33
Payout Ratio40.24%

Dividends

20231×
0.45Jun 7, 2023
20221×
0.50Jun 13, 2022
20211×
0.38May 20, 2021
20201×
0.18May 26, 2020